SouthState’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.01K Hold
2
– – ﹤0.01% 1136
2026
Q2
$1.07K Hold
2
– – ﹤0.01% 1099
2026
Q1
$1.05K Hold
2
– – ﹤0.01% 1038
2025
Q4
$1.16K Hold
2
– – ﹤0.01% 1090
2025
Q3
$918 Hold
2
– – ﹤0.01% 1086
2025
Q2
$606 Sell
2
-2
-50% -$596 ﹤0.01% 1391
2025
Q1
$1.32K Buy
+4
New +$1.31K ﹤0.01% 1273

Other funds holding MDGL

SouthState's MDGL Position: Q3 2026 in Review

SouthState held its Madrigal Pharmaceuticals (MDGL) position steady in Q3 2026 at 2 shares worth $1.01K. The position accounts for ﹤0.01% of the portfolio, ranked #1136.

SouthState first reported a position in MDGL in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.32K in Q1 2025. 332 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

  • SouthState held 2 shares of Madrigal Pharmaceuticals worth $1.01K as of Q3 2026.
  • SouthState left its Madrigal Pharmaceuticals share count unchanged in Q3 2026.
  • Madrigal Pharmaceuticals made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #1136 holding.
  • SouthState first reported a position in Madrigal Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
  • SouthState's Madrigal Pharmaceuticals position peaked at $1.32K in Q1 2025.
  • 332 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.